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Infiltration  of  sarcoid  granuloma  in  old  cutaneous  scars  is  one  of  the  uncommon  cutaneous  manifestations  of 
sarcoidosis. Here, we report the case of a 47-year-old female who presented with swelling and irritation in 5 old scars. 
She  had  acquired  these  scars  9  years  ago  in  a  traffic  accident.  An  incisional  scar  biopsy  revealed  noncaseating 
granulomas consistent with sarcoidosis. High-resolution CT (HRCT) revealed right paratracheal, both hilar, paraaortic, and 
subcarinal  lymphadenopathy  without  any  nodular  densities  in  both  lung  fields.  Successful  regression  of  cutaneous 
inflammation  was  achieved  using  a  short  course  of  oral  steroids.
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INTRODUCTION
Sarcoidosis is a systemic noncaseating granulomatous disorder 
of unknown origin that involves mainly the lungs, mediastinal and 
peripheral  lymph nodes,  eyes, and  skin.  Cutaneous  involvement 
occurs  in  25%  of  cases
1).
 
Skin  manifestations  include  erythema  nodosum,  lupus  pernio 
papules,  nodules,  and plaques. Infiltration of old cutaneous scars 
with  sarcoid  granuloma  in  the  active  phase  of  disease,  which  is 
known as scar sarcoidosis, is the most clinically characteristic and 
an  uncommon  cutaneous  manifestation  of  sarcoidosis
2).  Some 
cases  of  scar  sarcoidosis  have  been  reported  at  the  derma-
tology  department  of  various  hospitals  in  Korea
3, 4). 
Here,  we  present  a  case  of  a  patient  who  developed  scar 
sarcoidosis in old wounds that were acquired 9 years ago in a 
traffic  accident.
CASE REPORT
A 47-year-old female presented with swelling and irritation for 
10 months in 5 old scars that she had acquired 9 years ago in 
a  traffic  accident:  3  scars on  the  face, 1 on  the  left  knee,  and 
1  scar on  the  right  leg.  Dyspnea,
  night  sweats,  weight  loss,  or 
any  other  constitutional  symptoms  were  absent.  After  incisional 
skin  biopsy  of  the  right  leg  scar  performed  at  a  private  clinic, 
she was referred to our hospital for further consultation. Physical 
examination  findings  were  normal,  except  for  the  presence  of 
nodules at the sites of 5 scars on her lip, eyebrow, eyelid (Figure 
1),  knee,  and  leg. 
Routine laboratory tests,
  including white blood cell count and 
differential  cell  count,  and  liver  and  renal
  function  tests,  were 
normal. Erythrocyte sedimentation rate was 57 mm/h, and serum 
calcium  was  10.8  mg/dL  (normal:  8.5–10.8  mg/dL).  A  chest
 
radiograph  showed  enlarged  hilar  lymph  node  that  was 
suggestive  of  sarcoidosis  (Figure  2).  Pulmonary  function
  tests 
r e v e a l e d a  nor ma l  v e nt i l a t or y  pa t t e r n wi t h FVC ,  2. 99 L  ( 99% of  
predicted);  FEV1,  2.34
  L  (102%  of  predicted);  FEV1/FVC,  78%; 
and diffusing capacity
  of the lung for carbon monoxide, 96% of 
predicted. 
High-resolution  CT  (HRCT)  revealed  right  paratracheal,  both 
hilar,  paraaortic,  and  subcarinal  lymphadenopathy  without  any 
nodular  densities  in  both  lung  fields  (Figure  3).  Serologic  tests 
showed  that  both  C-reactive  protein  and  RA  (rheumatoid The  Korean  Journal  of  Internal  Medicine:  Vol.  23,  No.  4,  December  2008 214
Figure  1.  Small  scars  (arrows)  on  the  left  eyebrow  and  right  eyelid.
Figure  2.  Chest  radiograph  showing  bilateral  hilar  enlargement. 
Figure  3.  HRCT  of  the  thorax  revealing  both  hilar  lymphadenopathy 
without  any  lung  opacifications.
arthritis)  tests  were  negative.  Antinuclear  antibody  was  weakly 
positive,  and  serum  angiotensin  converting  enzyme  (ACE)  level 
was  40  IU/L  (normal:  18–5 5  I U / L ) .  S p u t u m  f o r  a c i d - f a s t  b a c i l l i  
and  tuberculin  skin  test  were  negative.  Ophthalmoscopic 
examination, including a slit-lamp study, revealed normal findings.
Biopsy specimens from the eyebrow and knee scars showed 
a noncaseating epitheloid granuloma (Figure 4); this finding was 
s i m i l a r  t o  t h e  r e s u l t  o f  b i o p s y  p e r f o r m e d  a t  t h e  p r i v a t e  c l i n i c . 
Detection of acid-fast bacilli was negative in the biopsy sample. 
The patient refused to undergo bronchoscopy. Scar sarcoidosis 
was  diagnosed  accompanying  the  involvement  of  hilar  and 
mediastinal  lymph  nodes.  The  patient  was  initially  treated  with 
topical  steroid,  which  did  not  cause  any  changes  in  the 
cutaneous  lesion.  After  a  short  course  of  oral  methylpredniso-
lone (24 mg per day for 4 weeks and gradually reduced over the 
next month), the visible inflammation in the scars regressed. She 
remained stable without recurrence for a follow-up period of 12 
months.  However,  hilar  lymphadenopathy  on  chest  radiography 
persisted.
DISCUSSION
S a r c o i d o s i s  i s  a  m u l t i s y s t e m  d i s e a s e  o f  u n k n o w n  e t i o l o g y  
characterized  by  the  formation  of  noncaseating  granulomas  in 
the affected organs. Skin sarcoidosis occurs in 25% of cases
1),
 
and  the  majority  of  patients  present  with  lupus  pernio, 
maculopapular  eruption,  subcutaneous  nodules,  and  erythema 
nodosum
2).
Scar sarcoidosis is itself rare
  but highly specific for cutaneous 
sarcoidosis  in  which  old  scars  are  infiltrated  with  noncaseating 
granulomas
5,  6). In addition to reactivation of the scars obtained 
from  previous  wounds,  scar  sarcoidosis  has  been  reported  to 
occur  at  the  sites  of  previous  intramuscular  injections,  tattoo 
scars,  blood  donation  sites,  and  herpes  zoster  sites
7) a f t e r  a  
varying period of 6 months to 59 years
8). Previous contamination 
of these scars with foreign material has been suggested to be a 
possible  underlying  cause
6).
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Figure  4.  Scar  biopsy  specimen  demonstrating  multiple  noncaseating 
epitheloid  cell  granulomas  with  scanty  lymphocytes  (H  &  E,  X  400).
cutaneous lesions developed systemic involvement after a period 
of 1 month to 1 year
9). Every patient with cutaneous sarcoidosis 
requires an initial work-up for systemic involvement, followed  by 
periodic  screening.  Scar  sarcoidosis  is  often  associated  with 
erythema  nodosum  and  hilar  as  well  as  with  generalized 
lymphadenopathy
8, 9). Our patient had skin manifestation of scar 
sarcoidosis  along  with  hilar  and  mediastinal  lymphadenopathy.
Cutaneous  sarcoidosis  is  often  not  suspected,  and  clinical 
diagnosis  is  made  on  subsequent  biopsy  after  excluding  other 
causes, particularly mycobacterial infection that is more prevalent in 
Korea. Recognition of cutaneous lesions is important because they 
provide  a  visible  clue  to  diagnosis  and  serve  as  an  easily 
accessible  source  of  tissue  for  histologic  examination.  The 
treatment  and  prognosis  of  cutaneous  sarcoidosis  is  primarily 
dependent  on  the  degree  of  systemic  involvement.  Topical 
steroid therapy may be sometimes effective for purely cutaneous 
sarcoidosis
1). For disfiguring lesions unresponsive to initial topical 
therapy or in the case of systemic involvement, oral therapy with 
prednisolone,  hydroxychloroquine,  and  methotrexate  may  be 
instituted
1, 10). 
Based on the above findings, it is essential that patients with 
inflammation  at  the  sites  of  preexisting  scars  should  be 
examined  and  investigated  for  sarcoidosis.
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